Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kathleen Lincoln
Observed names:
Kathleen A Lincoln,
Kathleen A. Lincoln
Institution:
Boehringer Ingelheim (United States)
Observed institution:
Boehringer Ingelheim (United States)
OpenAlex ID:
A5114036689
The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease
2022
·
Glenn A. Reinhart
, Paul C. Harrison
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
31
PDF
Six months later: The effect of Hurricane Katrina on health care for persons living with HIV/AIDS in New Orleans
2006
·
Rebecca A. Clark
, Lynn Besch
, et al.
·
AIDS Care
·
24
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications
2017
·
on behalf of the Ironwood team
, G. Todd Milne
, et al.
·
BMC Pharmacology and Toxicology
·
16
PDF
A soluble guanylate cyclase activator protects from diabetic nephropathy beyond standard of care in the ZSF1 rat
2015
·
Steven S Pullen
, Kathleen A Lincoln
, et al.
·
BMC Pharmacology and Toxicology
·
2
PDF
Show more works
View as search
Works count:
4
Citation count:
73
H-index:
3
I10-index:
3
Year
Topic
Type
